Follow
Gabriel Revon-Rivière
Gabriel Revon-Rivière
Unknown affiliation
No verified email
Title
Cited by
Cited by
Year
The BNT162b2 mRNA COVID-19 vaccine in adolescents and young adults with cancer: A monocentric experience
G Revon-Riviere, L Ninove, V Min, A Rome, C Coze, A Verschuur, ...
European journal of cancer 154, 30-34, 2021
532021
Clinical practice guideline for the prevention of oral and oropharyngeal mucositis in pediatric cancer and hematopoietic stem cell transplant patients: 2021 update
P Patel, PD Robinson, C Baggott, P Gibson, G Ljungman, N Massey, ...
European journal of cancer 154, 92-101, 2021
382021
High‐intensity end‐of‐life care among children, adolescents, and young adults with cancer who die in the hospital: A population‐based study from the French national hospital …
G Revon‐Rivière, V Pauly, K Baumstarck, C Bernard, N André, JC Gentet, ...
Cancer 125 (13), 2300-2308, 2019
362019
A randomized trial of physical activity in children and adolescents with cancer
P Saultier, C Vallet, F Sotteau, Z Hamidou, JC Gentet, V Barlogis, ...
Cancers 13 (1), 121, 2021
252021
Metronomic chemotherapy for children in low-and middle-income countries: Survey of current practices and opinions of pediatric oncologists
G Revon-Rivière, S Banavali, L Heississen, W Gomez Garcia, ...
Journal of Global Oncology 5, 1-8, 2019
162019
Metronomic maintenance with weekly vinblastine after induction with bevacizumab-irinotecan in children with low-grade glioma prevents early relapse
C Roux, G Revon-Rivière, JC Gentet, A Verschuur, D Scavarda, P Saultier, ...
Journal of Pediatric Hematology/Oncology 43 (5), e630-e634, 2021
102021
Translating the symptom screening in pediatrics tool (SSPedi) into French and among French-speaking children receiving cancer treatments, evaluating understandability and …
V Larouche, G Revon-Rivière, D Johnston, O Adeniyi, P Giannakouros, ...
BMJ open 10 (4), e035265, 2020
62020
Symptom Screening in Pediatrics Tool in children and adolescents with high-risk malignancies: a pilot study
S Szepetowski, P Saultier, N Andre, V Pauly, LL Dupuis, L Sung, ...
BMJ Supportive & Palliative Care 13 (e1), e70-e73, 2023
52023
Blood-Derived Liquid Biopsies Using Foundation One® Liquid CDx for Children and Adolescents with High-Risk Malignancies: A Monocentric Experience
F Cahn, G Revon-Riviere, V Min, A Rome, P Filaine, A Pelletier, S Abed, ...
Cancers 14 (11), 2774, 2022
52022
Ensuring access to innovative therapies for children, adolescents, and young adults across Canada: The single patient study experience
G Revon-Riviere, LC Young, EA Stephenson, K Brodeur-Robb, ...
Paediatrics & Child Health 28 (7), 399-403, 2023
32023
Favorable outcome of COVID-19 infection in a pediatric cancer patient receiving an anti-PD-L1/anti-CTLA-4 combination
G Revon-Riviere, C Soler, T Andrianarivony, S Fily, N André
Journal of Pediatric Hematology/Oncology 43 (7), e1045-e1046, 2021
22021
Patients requiring pediatric palliative care for advanced heart disease in France: a descriptive study
C La Fay, P Le Moine, L Blanc, W Abou Chahla, NP Hoang, ...
Archives de Pédiatrie 28 (7), 548-552, 2021
22021
First step toward high‐intensity end‐of‐life care definition in pediatric oncology: Response to bereaved parents' views on end‐of‐life care for children with cancer: Quality …
G Revon‐Rivière, S Szepetowski, P Saultier, N André
Cancer (0008543X) 127 (2), 2021
22021
ctDNA quantification improves estimation of outcomes in patients with high-grade osteosarcoma: a translational study from the OS2006 trial
B Audinot, D Drubay, N Gaspar, A Mohr, C Cordero, P Marec-Bérard, ...
Annals of Oncology, 2023
12023
BNT162b2 COVID-19 Vaccines in Children, Adolescents and Young Adults with Cancer—A 1-Year Follow-Up
C Donze, V Min, L Ninove, X de Lamballerie, G Revon Rivière, ...
Vaccines 11 (5), 989, 2023
12023
A sport room within the paediatric oncology ward
G Revon-Rivière, P Saultier, R Andrianarivony, C Vallet, N André
ecancermedicalscience 15, 2021
12021
Mortality and survival rates in children and adolescents enrolled in early phase trials with a dose-finding/dose-confirmation component: An innovative therapies for children …
F Carceller, F Bautista, A Castañeda, A Surun, A Wasti, G Revon-Riviere, ...
Journal of Clinical Oncology 37 (15_suppl), e21509-e21509, 2019
12019
How we approach Early Phase Clinical Trial and off-label therapy consults in Pediatric Oncology: The New Agents and Innovative Therapy (NAIT) team experience
G Revon-Rivière, P Tibout, J Cabral, A Siddiqi, A Doka, D Mills, K Fung, ...
EJC Paediatric Oncology, 100154, 2024
2024
Continuous Deep Sedation Until Death of Children at the End of Life: French Physicians' Opinions
CA Pisa, P Le Coz, MA Einaudi, B Tosello, M Katsogiannou, ...
Journal of Palliative Medicine, 2024
2024
Access to innovative therapies in pediatric oncology: Report of the nationwide experience in Canada
S Judd, G Revon‐Riviere, SA Grover, RJ Deyell, MI Vanan, VA Lewis, ...
Cancer Medicine 13 (3), e7033, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–20